Detecting radio- and chemoresistant cells in 3D cancer co-cultures using chromatin biomarkers
Abstract The heterogenous treatment response of tumor cells limits the effectiveness of cancer therapy. While this heterogeneity has been linked to cell-to-cell variability within the complex tumor microenvironment, a quantitative biomarker that identifies and characterizes treatment-resistant cell...
Main Authors: | Tina Pekeč, Saradha Venkatachalapathy, Anne R. Shim, Daniel Paysan, Michal Grzmil, Roger Schibli, Martin Béhé, G. V. Shivashankar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-47287-2 |
Similar Items
-
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer
by: Michal Grzmil, et al.
Published: (2022-12-01) -
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies
by: Kiran Challa, et al.
Published: (2023-12-01) -
Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [<sup>177</sup>Lu]Lu-PP-F11N
by: Michal Grzmil, et al.
Published: (2021-12-01) -
Evaluation of Actinium-225 Labeled Minigastrin Analogue [<sup>225</sup>Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
by: Yun Qin, et al.
Published: (2020-11-01) -
Actomyosin contractility as a mechanical checkpoint for cell state transitions
by: Saradha Venkatachalapathy, et al.
Published: (2022-09-01)